Sunshine Biopharma, Inc 4
4 · Sunshine Biopharma, Inc · Filed Aug 1, 2016
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Other
Common Stock
2016-07-08$0.00/sh+321,305,416$835,394→ 351,876,192 total(indirect: Owned by Advanomics Corporation, an entity controlled by Reporting Person.)
Footnotes (1)
- [F1]Issuer issued 321,305,416 shares of its Common Stock to Advanomics Corporation, a related party, in consideration for cancellation of two promissory notes payable to Advanomics Corporation in the aggregate amount of $835,394.